PJA2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.673600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.348800E-01
Normal-vs-Stage2
4.617400E-01
Normal-vs-Stage3
1.217570E-01
Normal-vs-Stage4
7.458800E-01
Stage1-vs-Stage2
3.654000E-01
Stage1-vs-Stage3
3.814500E-02
Stage1-vs-Stage4
6.397200E-01
Stage2-vs-Stage3
4.96270000005516E-06
Stage2-vs-Stage4
1.706150E-01
Stage3-vs-Stage4
1.057170E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.518000E-01
Normal-vs-AfricanAmerican
9.499200E-01
Normal-vs-Asian
2.076200E-01
Caucasian-vs-AfricanAmerican
4.835600E-01
Caucasian-vs-Asian
1.662250E-01
AfricanAmerican-vs-Asian
1.932780E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.962800E-01
Normal-vs-Female
5.483600E-01
Male-vs-Female
9.491400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.912200E-01
Normal-vs-Age(41-60Yrs)
9.884800E-01
Normal-vs-Age(61-80Yrs)
4.472400E-01
Normal-vs-Age(81-100Yrs)
5.465800E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.616200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.527800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.037420E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
8.655400E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
8.839300E-04
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.990000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.120820E-01
Normal-vs-Daily Drinker
1.136370E-01
Normal-vs-Weekly Drinker
3.538000E-01
Normal-vs-Occasional Drinker
9.984800E-01
Normal-vs-Social Drinker
9.825600E-01
Non Drinker-vs-Daily Drinker
7.217200E-01
Non Drinker-vs-Weekly Drinker
6.197400E-01
Non Drinker-vs-Occasional Drinker
3.766000E-02
Non Drinker-vs-Social Drinker
1.223970E-01
Daily Drinker-vs-Weekly Drinker
4.877800E-01
Daily Drinker-vs-Occasional Drinker
2.792000E-02
Daily Drinker-vs-Social Drinker
9.618200E-02
Weekly Drinker-vs-Occasional Drinker
1.651190E-01
Weekly Drinker-vs-Social Drinker
2.504600E-01
Occasional Drinker-vs-Social Drinker
9.631600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.584000E-01
Normal-vs-Grade 2
5.636500E-02
Normal-vs-Grade 3
7.380000E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.748200E-01
Grade 1-vs-Grade 3
8.635600E-01
Grade 1-vs-Grade 4
1.584000E-01
Grade 2-vs-Grade 3
7.119000E-01
Grade 2-vs-Grade 4
5.636500E-02
Grade 3-vs-Grade 4
7.380000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.132400E-01
Normal-vs-NonDiabetic
4.721000E-01
Diabetic-vs-NonDiabetic
8.185400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.339170E-01
Normal-vs-NoPancreatitis
5.505600E-01
Pancreatitis-vs-NoPancreatitis
2.195000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.353000E-01
Normal-vs-N1
4.567800E-01
N0-vs-N1
4.805000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.451000E-01
Normal-vs-TP53-NonMutant
8.934200E-01
TP53-Mutant-vs-TP53-NonMutant
1.685440E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
